Skip to main content
. 2022 Sep 12;14(18):4430. doi: 10.3390/cancers14184430

Figure 1.

Figure 1

CONSORT diagram—outline of the implementation of precision oncology in clinical practice. Initially, 109 patients were referred for molecular testing, aiming at individual targeted therapies. Thirty-three patients (30%) received matched therapies.